✦ LIBER ✦

Prognostic potential of topoisomerase IIα and HER2 in a retrospective analysis of early advanced breast cancer patients treated with adjuvant anthracycline chemotherapy

✍ Scribed by Beata Biesaga; Joanna Niemiec; Marek Ziobro; Joanna Wysocka; Anna Kruczak

Book ID: 113507346
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 271 KB
Volume: 20
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2011.03.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive value of apoptosis, prolifera

Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIα for anthracycline chemotherapy in locally advanced breast cancer

✍ G. Arpino; D. R. Ciocca; H. Weiss; D. C. Allred; P. Daguerre; L. Vargas-Roig; M. 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 202 KB

Microvessel Density and Status of p53 Pr

Microvessel Density and Status of p53 Protein as Potential Prognostic Factors for Adjuvant Anthracycline Chemotherapy in Retrospective Analysis of Early Breast Cancer Patients Group

✍ Beata Biesaga, Joanna Niemiec, Marek Ziobro 📂 Article 📅 2012 🏛 Springer Netherlands 🌐 English ⚖ 406 KB

Comparative value of tumour grade, hormo

Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy

✍ T. Petit; M. Wilt; M. Velten; R. Millon; J.-F. Rodier; C. Borel; R. Mors; P. Hae 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 169 KB

The Role of Serum CEA as a Prognostic In

The Role of Serum CEA as a Prognostic Indicator in Stage II and III Breast Cancer Patients Treated With Adjuvant Chemotherapy

✍ Richard L. Theriault; Gabriel N. Hortobagyi; Herbert A. Fritsche; Debbie Frye; R 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

Responses to chemotherapy or chemohormon

Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy: A subset analysis of CALGB study 8081

✍ Carl G. Kardinal; Michael C. Perry; Ann H. Korzun; Mary Alice Rice; Sandra Ginsb 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB 👁 2 views

The Cancer and Leukemia Group B (CALGB) evaluated the response to subsequent chemotherapy or chemohormonal therapy in 46 patients with advanced breast cancer treated previously with adjuvant chemotherapy that had been completed 6 months or more before protocol entry. The results were compared with 3

Evaluation of the prognostic value of HE

Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose–dense sequential adjuvant chemotherapy

✍ Ioannis Kostopoulos; Petroula Arapantoni-Dadioti; Helen Gogas; Savvas Papadopoul 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 406 KB